Edwards Lifesciences stock opened higher on September 17, 2026, following a significant gain of approximately 4.1% during the trading session that concluded on September 16, 2026. The shares traded around USD 89 on the NYSE, outperforming the broader S&P 500 index which declined by roughly...
Bullish Signals
Stock rose 4.1% to USD 89, outperforming S&P 500.
Closed near upper half of 52-week trading range.
Active trading interest and sentiment rebound observed.
Edwards Lifesciences (EW) shares edged higher on September 9, 2026, closing at USD 86.18 after the company raised its full-year 2026 revenue guidance. This positive move follows a robust second quarter where sales surged 13.6% year over year, driven by sustained demand for its heart...
Bullish Signals
Raised 2026 revenue guidance after Q2 sales rose 13.6% YoY.
Management confident in expanding top-line through 2026 on strong demand.
Bearish Signals
Stock underperformed S&P 500 with 7.99% vs 17.25% one-year return.
Lagged S&P 500 (16.35% vs 71.32%) over three years.
Edwards Lifesciences (NYSE: EW) is a specialized medical technology company dedicated exclusively to solving heart valve disease, having spent six decades becoming irreplaceable in the structural heart market. Every aspect of its business, from research programs to manufacturing, focuses on the four heart valves that...
Bullish Signals
Edwards Lifesciences possesses a unique combination of intellectual property, clinical evidence, and manufacturing expertise accumulated over 65 years that no competitor has yet replicated.
The company is transitioning into Transcatheter Mitral and Tricuspid Therapies (TMTT), a new multi-billion dollar franchise emerging exactly as patient populations receive first meaningful treatment options.
Edwards holds the foundational patents for TAVR acquired via the 2004 Percutaneous Valve Technologies deal, establishing a dominant position in the maturing TAVR market.
The company has established an evidentiary standard through landmark randomized controlled trials like PARTNER that competitors must match to gain market share.
Edwards addresses a structural, time-locked compounding of the patient pool driven by biological calcification and aging demographics without needing to grow market share.
Bearish Signals
The critical data regarding the lifespan of TAVR valves is currently holding back changes in treatment plans, as repeat surgery is highly challenging if the valve does not last at least 15 years.
Edwards is navigating a strategic transition where its dominant TAVR technology is maturing and no longer offers the hypergrowth driver it once possessed.
Edwards Lifesciences Corp. has agreed to pay a $10 million penalty related to its 2024 acquisition of JC Medical, which was formerly a subsidiary of Genesis MedTech. The Federal Trade Commission alleges that both Edwards and Genesis intentionally structured the transaction to avoid federal premerger...
Bearish Signals
Company faces $10M antitrust penalty for JC Medical acquisition.
Stock price dropped 2% to $90.03 after settlement news.
Genesis MedTech liable for additional $2M penalty.
24/7 Wall St. has issued a price target of $111.36 for Edwards Lifesciences Corp (EW) over the next 12 months, implying a 17.45% upside from the current trading price of $94.82. The analysis categorizes the stock as attractively valued with a favorable risk-reward profile for...
We use cookies to run the site and, only if you allow it, for live chat, analytics, personalization and ad measurement.
We use cookies to:
Deliver and maintain our services, protect against spam, fraud and abuse
Offer a live chat with our team (Enuchat, optional)
Measure audience engagement and site statistics to understand how our services are used (Google Analytics, optional)
Remember your quiz progress and tailor the knowledge base to your skill level (optional)
Measure how our ads on Facebook and Instagram perform, including whether a visit leads to a confirmed sign-up, matched to your Facebook or Instagram account using hashed contact details you enter (Meta Pixel, optional)
Optional cookies are only set if you allow them. You can accept all, reject all or choose per category, and change your choice at any time via the "Manage Cookies" link in the footer. Google and Meta may process this data in the USA. More in our Privacy Policy.
Manage cookie preferences
Necessary cookiesAlways active
Required for the website to function. These cannot be disabled.
Cookie
Purpose
Duration
PHPSESSID
Session identifier for login, security tokens, and site functionality
Session
cookie_consent
Stores your cookie preferences
1 year
Functional cookies
Show the live chat button so you can message our team. The Enuchat chat widget stores a visitor ID in your browser and sends your chat messages to Enuchat. When this is off, the chat is not loaded.
Cookie
Purpose
Duration
enuchat_visitor_id
Keeps your chat conversation linked to this browser (Enuchat, browser storage)
Until you clear it or turn this off
Analytics cookies
Help us understand how visitors use our website with Google Analytics, provided by Google LLC. Google receives pages visited, device data and an IP address, and may process them in the USA. If you also allow marketing cookies, the Google tag can detect contact details you enter or see on our pages, such as your email address, phone number, name or address, hash them before sending and pass them to Google so it can match your visits to a Google account for measuring our ads. Hashed details are still personal data. See how Google uses information from sites that use its services.
Cookie
Purpose
Duration
_ga
Distinguishes unique visitors (Google Analytics)
2 years
_ga_*
Maintains session state (Google Analytics)
2 years
Personalization cookies
Remember your quiz progress and work out your investing level so we can recommend knowledge-base articles and the right reading depth for you. Stored only on your device.
Cookie
Purpose
Duration
bes_user_level
Your quiz-derived investing level, used to tailor content
1 year
Marketing cookies
Let Meta (Facebook and Instagram) measure how our ads perform, using the Meta Pixel. Meta Platforms Ireland Ltd. receives the pages you visit and, when you confirm the email address of a new account, a "completed registration" event, together with browser identifiers and your IP address. Meta's automatic advanced matching also reads contact details you type into forms on our site, such as your email address or name, hashes them in your browser and sends them with these events so Meta can match them to a Facebook or Instagram account. Hashed details are still personal data. These events are sent from your browser and may also be forwarded to Meta through Meta's Conversions API Gateway. Our own server also sends page visits and completed-registration events directly to Meta's Conversions API, with your IP address, browser user agent and Meta browser identifiers, so Meta can count it once. To help Meta match these visits, your browser and our server also send a random visitor ID from our own cookie and, if you are signed in, your account ID, your confirmed email address and the name, city, postal code and country saved in your profile, all hashed first. We and Meta are joint controllers for collecting and sending this data, and Meta's further use, which may include processing in the USA, is described in the Meta Privacy Policy. When this is off, the Meta Pixel is not loaded and no page visit or registration event is sent to Meta. Together with analytics cookies, this choice also lets Google receive hashed contact details, as described under Analytics cookies.
Cookie
Purpose
Duration
_fbp
Identifies browsers for Meta ad measurement (Meta Pixel)
3 months
_fbc
Stores the Meta ad click that brought you here (Meta Pixel)
3 months
_bes_meid
Random visitor ID, sent to Meta only hashed, so your visits can be matched (Meta Pixel and Conversions API)